Prognostic significance of cyclin D1 protein levels in early‐stage larynx cancer treated with primary radiation
Yoo S, Carter D, Turner B, Sasaki C, Son Y, Wilson L, Glazer P, Haffty B. Prognostic significance of cyclin D1 protein levels in early‐stage larynx cancer treated with primary radiation. International Journal Of Cancer 2000, 90: 22-28. PMID: 10725854, DOI: 10.1002/(sici)1097-0215(20000220)90:1<22::aid-ijc3>3.0.co;2-t.Peer-Reviewed Original ResearchConceptsEarly-stage larynx cancerLocal relapsePrognostic significanceLarynx cancerTotal median dosePrimary radiation therapySquamous cell carcinomaCell nuclear antigen levelsParaffin-embedded specimensSignificant clinical implicationsCase-control designPercent distributionLarynx cancer patientsCyclin D1 protein levelsCyclin D1 levelsMedian doseControl patientsLocal recurrenceAntigen levelsCancer patientsCell carcinomaDaily fractionsRadiation therapyIndex caseClinical informationPSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients
Peschel R, Robnett T, Hesse D, King C, Ennis R, Schiff P, Wilson L. PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients. International Journal Of Cancer 2000, 90: 29-36. PMID: 10725855, DOI: 10.1002/(sici)1097-0215(20000220)90:1<29::aid-ijc4>3.0.co;2-5.Peer-Reviewed Original ResearchConceptsPostoperative radiation therapyBNED survival ratesAdjuvant radiation therapyHigh-risk patientsSalvage radiation therapyPostoperative prostate cancer patientsProstate cancer patientsRadiation therapySurvival ratePSA levelsBiochemical failureCancer patientsBiochemical disease-free survival ratesHigh-risk surgery patientsDisease-free survival ratesAdjuvant radiation groupPreoperative PSA levelSeminal vesicle involvementEarly prostate cancerLife table methodAdjuvant settingSalvage radiationClinical recurrenceSurgery patientsClinical factors